Literature DB >> 36258025

Evaluation of choroidal thickness with OCT in COVID-19 patients with high D-dimer levels.

Fatih Cem Gül1, Esra Suay Timurkaan2.   

Abstract

To evaluate retinal and choroidal thickness with optical coherence tomography (OCT) to detect retinal and choroidal pathologies in coronavirus disease 2019 (COVID-19) patients with high D-dimer levels. Thirty patients who were hospitalized in the intensive care unit due to severe acute respiratory syndrome coronavirus 2 and whose D-dimer levels were high during this period, who applied to the internal medicine outpatient clinic between 15 and 30 days after discharge, and 30 healthy volunteers with similar age and gender as the control group was included in the study. After full ophthalmological examination, central foveal and choroidal thicknesses were evaluated using optical coherence tomography. Statistical analysis of the study data demonstrated that there was no significant difference between the groups in terms of age or gender (p > 0.05). There was also no statistically significant difference between the groups in terms of central foveal thickness, central choroidal thickness, or nasal 500, nasal 1500, temporal 500, or temporal 500 micron distances (p > 0.05 for all parameters). Choroidal and retinal vascular thicknesses were not affected in the short term in COVID-19 patients hospitalized in the intensive care unit.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36258025      PMCID: PMC9579170          DOI: 10.1038/s41598-022-21579-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  50 in total

1.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

2.  Metabolic dependence of photoreceptors on the choroid in the normal and detached retina.

Authors:  R A Linsenmeier; L Padnick-Silver
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

3.  Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.

Authors:  Maria Casagrande; Antonia Fitzek; Klaus Püschel; Ganna Aleshcheva; Heinz-Peter Schultheiss; Laura Berneking; Martin S Spitzer; Maximilian Schultheiss
Journal:  Ocul Immunol Inflamm       Date:  2020-05-29       Impact factor: 3.070

4.  Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19).

Authors:  Amparo Ortiz-Seller; Lucía Martínez Costa; Antonio Hernández-Pons; Elia Valls Pascual; Alicia Solves Alemany; Mara Albert-Fort
Journal:  Ocul Immunol Inflamm       Date:  2020-10-06       Impact factor: 3.070

Review 5.  Therapeutic targets of renin-angiotensin system in ocular disorders.

Authors:  Rajesh Choudhary; Mandeep Singh Kapoor; Amrita Singh; Surendra H Bodakhe
Journal:  J Curr Ophthalmol       Date:  2016-10-20

6.  Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-30       Impact factor: 3.944

7.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

8.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Authors:  Julie Helms; Charles Tacquard; François Severac; Ian Leonard-Lorant; Mickaël Ohana; Xavier Delabranche; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Florence Fagot Gandet; Samira Fafi-Kremer; Vincent Castelain; Francis Schneider; Lélia Grunebaum; Eduardo Anglés-Cano; Laurent Sattler; Paul-Michel Mertes; Ferhat Meziani
Journal:  Intensive Care Med       Date:  2020-05-04       Impact factor: 17.440

Review 9.  COVID-19 update: Covid-19-associated coagulopathy.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.